# Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women

> **NCT00683800** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 2186 (actual)

## Conditions studied

- Vasomotor Symptoms

## Interventions

- **DRUG:** desvenlafaxine succinate (DVS) SR
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00683800
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 2186 (ACTUAL)
- **Last updated:** 2011-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00683800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00683800, "Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00683800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*